While a majority of the efforts to take advantage of PrPC in therapeutic development focuses on the regulatory role of PrPC in cellular processes, the properties of PrPC as a cell surface protein can be exploited to formulate a different approach to treating renal carcinoma. The gene discussed is PRNP; the disease is renal carcinoma.